The turnaround is real on the income statement — first non-GAAP operating profit in three years, Europe doubling, positive free cash flow — and the stock has still fallen by a third since it printed. The market is pricing a U.S. residential market that stays frozen until FEOC is defined, and a 2029 Investor Day plan it does not believe yet.
SolarEdge reported Q2 on August 5: revenue $346.2M (+20% y/y, +12% q/q), non-GAAP gross margin 28.6% (from 13.1% a year ago), non-GAAP operating income $10.2M — the first in nearly three years — non-GAAP EPS $0.05 and free cash flow $3.1M. The beat was sold: the stock fell ~16% the next morning on a Q3 guide of $310–340M revenue and 22–26% non-GAAP gross margin, which management attributed to European seasonality (~$15M at the midpoint), no usual Q3 pickup in U.S. residential, and fixed-cost under-absorption rather than product economics. It has since drifted to $32.82, 33% below the pre-print level, with a stack of price-target cuts into the Nov 4 report (JPM $38, Susquehanna $32, Barclays $36, BMO $28 Underperform, Deutsche "Catalyst Call: Sell", Citi $30 Sell).
Two things in the Q2 margin need subtracting before the number is compared to the guide. The 28.6% included a $13.3M IEEPA tariff refund; without it, gross margin was roughly 24.7% — inside the 22–26% Q3 range, which means the guide is not the step-down the headline suggested. And the Q3 guide excludes further IEEPA refunds ($11.5M was received in July) and any material safe-harbor pull-forward — the two items that make the Enphase comparison flattering to Enphase. The Street sits at $327M and −$0.02 for Q3 and $318M / −$0.06 for Q4: a company guided to be roughly breakeven that the market treats as a loss-maker.
| Line | Q2 26 | Q1 26 | Q2 25 | Read |
|---|---|---|---|---|
| Revenue ($M) | 346.2 | 310.5 | 289.5 | +20% y/y; U.S. $154.9M (−2% q/q), Europe $154.4M (+36% q/q, >2× y/y), Intl $36.9M |
| Non-GAAP gross margin | 28.6% | 23.5% | 13.1% | ~24.7% ex the $13.3M IEEPA refund; 45X credits monetized support FCF |
| Non-GAAP opex ($M) | 88.5 | 97.7 | 85.2 | Restructuring done; Q3 guide $86–91M |
| Non-GAAP operating income ($M) | 10.2 | (24.8) | (48.3) | First profit since 2023; GAAP still −$16.0M |
| Non-GAAP EPS | $0.05 | ($0.43) | — | GAAP −$0.50 |
| Free cash flow ($M) | 3.1 | 20.7 | (9.1) | Positive for the year expected; capex $60–80M |
| Net cash ($M) | 264.6 | — | 244.2 (12/25) | Cash $527M + securities; converts $332M net; inventory still $600M |
Channel: management called inventory "normalized" but said distributors are cautious and reducing stock while they wait for FEOC definitions — which is the same thing as saying sell-in will lag sell-through for another quarter or two. U.S. residential is expected to stay weak until tax-equity funding and FEOC clarity arrive; the company holds over 50% of U.S. C&I rooftop installations and its U.S.-made products meet domestic-content and FEOC rules, which is the one structural edge it has over Chinese-sourced competitors. Storage prices were "stable per product"; memory-cost pressure from data-center demand was flagged on the component side.
The September 10 Investor Day set the frame the stock now trades against: $2.4B of revenue and a 35% gross margin by 2029, roughly 1.8× this year's revenue, driven by Nexis (the new residential platform: three-phase in Europe from Q2, U.S. from Q3, single-phase Q1 2027) lifting revenue per site, storage mix, and the solid-state transformer program for 800 VDC AI data centers (lab system end-2026, pilots 2027, revenue 2028; a protection framework published with NVIDIA, an Infineon collaboration on solid-state breakers, a showcase at NVIDIA's ecosystem event in October). The sell-side reaction was split (JPM and Mizuho raised, Morgan Stanley cut) and the stock has given back the entire post-Investor-Day bounce, which tells you the plan is being discounted at a high rate.
Gross margin ex-refunds against the 22–26% guide, and the Q4 revenue guide against $318M. The bull case lives or dies on whether the Q2 margin was scale (then Q3 at ~24% on lower revenue is consistent and Q4 recovers with volume) or mix and one-offs (then the 35% target is a slide). Second, U.S. revenue — $155M in Q2, −2% q/q — is the line that has to stop falling for the Street to believe anything about 2027; a Nexis U.S. launch quarter with U.S. revenue still down is the bear's print. Third, cash: inventory at $600M against $1.3B of revenue is 165 days; working it down is the FCF story, and FCF is what funds the 2029 converts without dilution.
At $32.82 the equity is ~$2.0B and EV ~$1.75B after $265M of net cash — about 1.3× FY26E revenue of ~$1.30B. There is no earnings multiple to anchor on (FY26 consensus is a ~$0.46 loss); the stock trades on EV/sales, gross-margin trajectory and cash. Our June snapshot (50/43/35) assumed the margin recovery would be rewarded; it was not, and the U.S. residential freeze is now explicit in the guide, so we reset lower with a wider distribution. Fair values are independent house estimates on 2027 revenue and margin.
| Name | Last | Today | 52-wk low | Above low | 52-wk high | Note |
|---|---|---|---|---|---|---|
| SEDG | 32.82 | +3.7% | 28.21 | +16% | 81.25 | Reports Nov 4 pre-market; 134% IV |
| ENPH | 30.15 | −0.7% | 25.78 | +17% | 73.74 | Reports tonight — the read-through (see our ENPH note) |
| RUN | 7.76 | +6.8% | 6.78 | +14% | 21.95 | The U.S. TPO channel |
| FSLR | 176.37 | +4.9% | 165.86 | +6% | 320.95 | Utility-scale; reports Thursday |
| TAN | 42.21 | +3.6% | 40.44 | +4% | 75.60 | Group ETF, at the low |
The desk read: the June snapshot was a margin-recovery call and the margin recovered — then the market moved the goalposts to the U.S. residential line and FEOC. At ~1.3× sales with net cash and a profitable Q2 ex-refunds, the equity is not expensive; it is uncertain, and 134% implied vol says so. Levels: the $28.21 low and $29.51 (the August/October floor) below; $36 (the September Investor Day range) and $40–41 (post-Q2 gap) above.
For educational/entertainment purposes. Sikuli Research publishes independent opinions; nothing here is investment advice, a research report under FINRA rules, or a solicitation to buy or sell any security. Fair-value scenarios are the author's assumptions and may change without notice. Prices are as of the time stated and should be confirmed against a live feed. The author may hold positions, long or short, in securities mentioned.